Berlex, Inc.

Hormone maker comments on WHI estrogen-only study data

Published in Hospital Business Week, May 16th, 2004

Newly published results of the U.S. National Institutes of Health Women's Health Initiative (WHI) trial should reassure women of the robust effect estrogen has on preventing bone fracture, with no increased risk of breast cancer, when followed for about 7 years.

Authors of the Journal of the American Medical Association (JAMA) article also confirmed the established risk of stroke for women taking the dosage studied in the WHI. By quantifying this known risk more clearly, this study will help women and their healthcare providers individualize therapy for vasomotor symptoms and osteoporosis prevention, given their own risk/benefit profiles.

"The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week

Source: Hospital Business Week (2004-05-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry